On June 26, China Life Insurance (02628.HK) fell 3.3% in regular trading, trading at HK$27.56/share, with turnover of HK$409 million.

On the news front, China Life's share price has fallen below Goldman Sachs' neutral-rated 12-month target price of HK$28.5 for multiple consecutive days, corresponding to 1.0x estimated 2027 price-to-book ratio, with institutional valuation overhang persisting. Additionally, financial regulators in Yunnan and Anhui previously imposed administrative penalties on multiple China Life branch offices for violations including fabricating business documents and delayed claims processing, with compliance risks continuing to weigh on sentiment. The prior session's rebound failed to establish a firm footing above the target price level, and multiple bearish catalysts are now converging to intensify near-term pullback pressure.

Within the Life and Health Insurance sector, the broader sector declined in tandem. Among individual stocks, AIA fell 2.35%, Ping An fell 2.41%, New China Life fell 3.91%, China Taiping fell 3.87%, and Sunshine Insurance fell 2.2%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)